UPDATED AGENDA: Drug Pricing Policies in the United States and Globally image

October 24, 2018 8:00 AM - 5:00 PM
Conferences
2018-2019
Harvard Law School, Wasserstein Hall, Milstein East (2036)
1585 Massachusetts Ave., Cambridge, MA

Register for this event

Description

Join us for a one-day conference exploring the current pharmaceutical pricing landscape. This event will bring together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants will assess the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We will also explore and articulate best practices to expand access to medicines and develop a plan for disseminating these practices more widely.

This event is free and open to the public, but seating is limited and registration is required. Register now!

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society.

Agenda (in development)

8:00 - 8:30am, Registration

8:30 - 8:45am, Welcome Remarks

  • Daniel Aaron, JD/MD Candidate, Class of 2020, Harvard Law School and Boston University School of Medicine

  • I. Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

8:45 - 9:30am, Keynote Address

9:30 - 10:45am, Panel I: From Development to Delivery in the United States

  • Michael Caljouw, Vice President, State Government and Regulatory Affairs, Blue Cross Blue Shield of Massachusetts

  • Sean Dickson, Officer, Drug Spending Research Initiative, The Pew Charitable Trusts

  • Surya Singh, Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health

  • Moderator: Carmel Shachar, Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and Lecturer at Law, Harvard Law School

10:45 - 11:00am, Break

11:00am - 12:15pm, Panel II: From Development to Delivery Globally

  • Amy Flood, Senior Vice President, Public Affairs, Gilead Sciences, Inc.

  • Lauren Galinsky, Senior Clinical Operations Strategy Advisor, Partners in Health

  • Hannah Kettler, Senior Program Officer, Industry Leadership Engagement and Thinkubator Lead, Bill & Melinda Gates Foundation

  • Tsveta Milanova, Senior Vice President, Global Value, Access and Policy, Alexion

  • Moderator: Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

12:15 - 12:45pm, Keynote Address

  • Joe GroganAssociate Director, Health Programs, Office of Management and Budget

12:45 - 1:45pm, Networking Lunch

1:45 - 3:00pm, Panel III: Best Practices in Pricing Policy for Essential Drugs

  • Peter B. BachDirector, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

  • Annette Gaudino, ​HIV/HCV Project Co-Director, Treatment Action Group (TAG)

  • Aaron S. Kesselheim, Director, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham & Women’s Hospital, and Associate Professor of Medicine, Harvard Medical School

  • Jami Taylor, Managing Director, Stanton Park Capital

  • Moderator: William W. FisherWilmerHale Professor of Intellectual Property Law, Harvard Law School, and Faculty Director, Berkman Klein Center for Internet and Society at Harvard University

3:00 - 3:30pm, Break

3:30 - 4:45pm, Panel IV: Innovations in Drug Delivery and Policy

  • Sara Gerke, Research Fellow in Precision Medicine, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Muhammad Zaman, Professor, Biomedical Engineering, Boston University

  • Moderator: Ashveena Gajeelee, Research Fellow, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

Register

This event is free and open to the public, but seating is limited and registration is required. Register now!

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society.

Tags

biotechnology   fda   global health   health care costs   health care finance   health law policy   innovation   international   pharmaceuticals   public health   regulation   research   research funding